VENTRUS BIOSCIENCES ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Ventrus Biosciences, Inc. of

VENTRUS BIOSCIENCES ALERT: Levi & Korsinsky Notifies Investors With Losses on 
Their Investment in Ventrus Biosciences, Inc. of Class
Action Lawsuit and the Deadline of July 8, 2013 to Seek a Lead
Plaintiff Position 
NEW YORK, NY -- (Marketwired) -- 06/05/13 --  Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
United States District Court for the Southern District of New York on
behalf of investors who purchased Ventrus Biosciences, Inc.
("Ventrus" or the "Company") (NASDAQ: VTUS) stock between December
17, 2010 and June 25, 2012 (the "Class Period"). 
For more information, click here:
http://zlk.9nl.com/ventrus-biosciences-vtus/.  
The complaint alleges that during the Class Period, defendants issued
materially false and misleading statements and omitted materially
relevant facts regarding iferanserin (VEN 309) ("VEN 309"), the
Company's chemical entity for the treatment of internal hemorrhoids.
On June 25, 2012, Ventrus announced that VEN 309 had failed its Phase
III trial before the FDA and that the Company was abandoning plans
for further development of the treatment. In response to this news,
the price of Ventrus common stock fell over 50% from a close of
$12.26 on June 22, 2012 to a close of $5.02 per share on June 25,
2012. 
If you suffered a loss in Ventrus you have until July 8, 2013 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at (877)
363-5972, or visit http://zlk.9nl.com/ventrus-biosciences-vtus/. 
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, and Washington D.C. The firm has extensive expertise in
prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and
shareholder lawsuits. Attorney advertising. Prior results do not
guarantee similar outcomes. 
CONTACT: 
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004 
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com 
 
 
Press spacebar to pause and continue. Press esc to stop.